Incanthera (AQSE:INC) Beginning Cash Position : £0.00 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Beginning Cash Position?

Incanthera's Beginning Cash Position for the quarter that ended in Sep. 2023 was £0.00 Mil.

Incanthera's quarterly Beginning Cash Position declined from Sep. 2022 (£0.30 Mil) to Mar. 2023 (£0.19 Mil) and declined from Mar. 2023 (£0.19 Mil) to Sep. 2023 (£0.00 Mil).

Incanthera's annual Beginning Cash Position increased from Mar. 2021 (£0.39 Mil) to Mar. 2022 (£0.96 Mil) but then declined from Mar. 2022 (£0.96 Mil) to Mar. 2023 (£0.30 Mil).

Incanthera Beginning Cash Position Historical Data

The historical data trend for Incanthera's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Beginning Cash Position Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Beginning Cash Position

0.18

0.39

0.96

0.30

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Beginning Cash Position	Get a 7-Day Free Trial			0.96	0.63	0.30	0.19	-

Incanthera Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Incanthera Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Incanthera's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines